Intention tremor, parkinsonism, and generalized brain atrophy in male carriers of fragile X
Citation Manager Formats
Make Comment
See Comments

Abstract
The authors report five elderly men with the fragile X premutation who had a progressive action tremor associated with executive function deficits and generalized brain atrophy. These individuals had elevated fragile X mental retardation 1 gene (FMR1) messenger RNA and normal or borderline levels of FMR1 protein. The authors propose that elevations of FMR1 messenger RNA may be causative for a neurodegenerative syndrome in a subgroup of elderly men with the FMR1 premutation.
Fragile X syndrome (FXS) is caused by a trinucleotide repeat expansion (the full mutation is >200 CGG repeats) in the fragile X mental retardation 1 gene (FMR1). The full mutation leads to methylation and subsequent transcriptional silencing with a consequent deficit of FMR1 protein (FMRP).1 The premutation, an expansion of 50 to 200 CGG repeats, has a prevalence in the general population of approximately 1 per 700 men and 1 per 250 women.2 Carriers of the premutation typically do not show the full FXS phenotype, but comprise a subgroup that may have some physical features of FXS1,3⇓ or mild cognitive and emotional problems.4-6⇓⇓ Premature menopause, present in approximately 16% of women carrying the premutation but in none with the full mutation, is considered a phenotypic characteristic unique to the premutation.7 Men with 55 to 100 CGG repeats have FMR1 messenger RNA (mRNA) levels that are two to four times higher than normal, and men with 100 to 200 CGG repeats have FMR1 mRNA levels four to ten times normal, despite mildly reduced FMRP levels.8 Thus, elevated FMR1 mRNA represents a molecular phenotype for men with the premutation, and may reflect a defect in translation of the mRNA into FMRP.8 We report five men with the premutation and elevated FMR1 mRNA levels who had action tremors associated with executive function deficits and slowly progressive neurodegenerative disorders.
Case reports. Patient 1.
A 63-year-old right-handed grandfather of a boy with FXS had onset of an action tremor in his right hand at age 54. The tremor progressed over 2 years to involve his left hand, interfering with fine motor abilities and causing him to retire from his career as an electrician at age 58 years. His handwriting became illegible at age 58, and by age 61 he required help from his wife for many activities of daily living. His tremor occurred at rest, but was most prominent with action. His gait was wide-based, and he frequently fell.
On examination he had masked facies, monotonous, slurred speech, mild saccadic pursuit, and bilateral hearing loss. He had a relatively symmetric, 4- to 6-Hz, large-amplitude intention tremor of the upper extremities, a static bilateral upper extremity postural tremor, and an intermittent resting tremor of his right thumb. On finger-to-nose testing he had bradyteleokinesia without hypo- or hypermetria. Handwriting was large and completely illegible. He had upper extremity dysdiadochokinesis, ataxia on heel-to-shin movements, and a wide-based, slow, and lurching gait. Muscle stretch reflexes were reduced in all extremities and absent at the ankles, and plantar responses were flexor. Vibration sense was absent but position sense was preserved in the great toes. The table contains the results of molecular studies, cognitive testing, and MRI.
Clinical and molecular findings in elderly men with the fragile X premutation
Patient 2.
A 63-year-old right-handed grandfather of two children with FXS, with a PhD in education, had gradual onset of shaking in his right hand at age 55, which interfered with writing. The tremor worsened and become bilateral. Over the past 2 years his wife noticed a resting tremor in his right hand and a general slowing of movement. His activities of daily living took longer to perform. He had difficulty with balance, and fell occasionally. Memory problems were present for 2 years. He took sertraline for depression, anxiety, and obsessive–compulsive symptoms. Neurologic examination revealed a mild postural tremor of the right upper extremity, and a 4- to 6-Hz intention tremor with finger-to-nose testing. The tremor was most pronounced with handwriting, which was large and poorly legible. He had masked facies, diminished amplitude of finger tapping, mild rigidity, and an intermittent slow resting tremor in the right upper extremity. Vibration sense was reduced in his great toes.
Patient 3.
A 62-year-old right-handed grandfather of a boy with the full mutation, this patient had consumed alcohol heavily, stopping at age 57 years, when he noticed a tremor in his right arm. The tremor became much more apparent and disabling when he stopped drinking, and progressed to bilateral involvement by age 58. For the past 2 years he drank liquids through a straw because of difficulty holding a cup; his wife cut his foods, his writing was illegible, and he required assistance with buttons and dressing. He switched from using his right hand primarily to his left at age 58, and stopped driving at age 61. He was unsteady, sometimes listing to the right, with frequent stumbling in the forward direction and occasional falls. He had used a cane for the past 2 years and a walker for the past year.
Examination of the cranial nerves showed facial masking, mild saccadic pursuit, monotone speech, and bilateral hearing loss. With finger-to-nose testing he had a bilateral, upper extremity, 4- to 6-Hz, large-amplitude intention tremor and dysmetria. A resting and a static, postural tremor were present in both arms. He was unable to write. There was loss of check in the upper extremities and dysdiadochokinesis. Heel-to-shin movements were ataxic. He had slight cogwheel rigidity in the right arm and mild rigidity in both legs. His gait was wide-based and slow, his steps were short, his arm swing was reduced, and he turned en bloc. Muscle stretch reflexes were reduced in all extremities and absent at the ankles. Vibration sense was markedly reduced in the right great toe and absent in the left. MR images from Patient 3 are shown in the figure.
Figure. (A and B) Patient 3. T1 axial and sagittal images demonstrate prominent ventricles with cerebral, brainstem, and cerebellar atrophy. Note the particularly severe frontal and parietal atrophy, which has lead to excess fluid graying the sulci seen frontally on sagittal view.
Patient 4.
This case was identified retrospectively. The patient, who died in 1988, was the grandfather of a boy with FXS. As his daughter had 75 CGG repeats and his wife was negative for the FMR1 mutation, Patient 4 was therefore an obligate premutation carrier. He had first experienced an intermittent intention tremor in his left hand at age 57 years while working as a professor in Nigeria. His handwriting became tremulous, and he found it difficult to button clothing and tie shoelaces. His wife noted the gradual development of memory and concentration problems.
Thought to have PD with left-sided rigidity, the patient was given carbidopa and l-dopa, which improved his tremor and rigidity. His condition continued to deteriorate, and by age 64 he had developed a marked resting and intention tremor bilaterally, cogwheeling in his lower extremities, and dementia. His diagnosis was modified to atypical PD. His symptoms gradually worsened and he eventually became bedridden before dying from complications of a kidney infection at age 69.
Patient 5.
Patient 5 was a 70-year-old, right-handed former college professor and grandfather of two children with FXS. At age 61 years he first noticed a tremor in his right hand, which subsequently developed in the left hand and began interfering with his handwriting. Over the past 3 years his tremor was present daily with movement, and intermittently at rest. At age 66, he found it difficult to get a key into the car door lock because of his tremor. Within the past year, he had problems with spilling liquids. Over the past 4 years he had fallen occasionally, and his gait sometimes drifted to one side. His wife noticed that he had mild short-term memory problems and compulsive hand washing. Results of his neurologic examination were similar to those of the first three cases, including impaired vibration and position sense in the distal lower extremities. The cerebellar and parkinsonian findings are described in the table.
Discussion.
All five men appear to have similar findings of differing severity: a progressive action tremor, cerebellar dysfunction, cognitive decline, and parkinsonism associated with generalized brain atrophy (see the table). The slow intention tremor is the most obvious clinical feature, suggesting particular involvement of the dentate nuclei or cerebellar outflow tracts. Additionally, all five men were impotent and had signs of peripheral neuropathy. The cognitive component appears to begin with executive function deficits (see the table) but such problems may be common in premutation male carriers without an intention tremor.9 The cognitive decline appears to be progressive, with memory loss, decline in executive functioning, and eventual dementia in two of the patients described here.
The prevalence of this progressive neurologic problem among men with the premutation is not known, and warrants a survey of this population. The syndrome described here is different from the previous problems, such as attention deficit hyperactivity disorder, anxiety, and premature menopause, that have been reported in individuals with the premutation,1,4-7⇓⇓⇓⇓ suggesting that heterogeneity in the clinical phenotype depends on age and perhaps sex. Although the molecular basis of this neurologic phenotype is unknown, its apparent restriction to the premutation range argues against a causative role of lowered FMRP levels, which are more pronounced in the full mutation range. As a tentative alternative hypothesis, progressive nervous system degeneration may result from either direct or indirect effects of the elevated FMR1 mRNA levels, which were seen in four of the five case studies (see the table). Analogous gain-of-function effects of abnormal mRNA production or localization have been proposed for the CTG expansion in myotonic dystrophy.10 In any case, it is imperative that additional individuals with both premutation and full mutation alleles be screened for tremor, and that individuals with action tremor associated with cognitive decline and mild parkinsonism be screened for fragile X. Further studies of the biological consequences of elevated FMR1 mRNA, including neuropathologic studies of autopsy material, are warranted.
Acknowledgments
Supported by grant HD36071, National Institute of Child Health and Human Development; grant MCJ-089413, Maternal and Child Health Bureau; grant MO1 RR00069, General Clinical Research Centers Program, National Center for Research Resources, NIH; and The Children’s Hospital Research Institute, Denver, CO.
- Received September 18, 2000.
- Accepted March 4, 2001.
References
- ↵
Hagerman RJ. Fragile X syndrome. In: Neurodevelopmental disorders: diagnosis and treatment. New York: Oxford University Press, 1999: 61–132.
- ↵
- ↵
- ↵
- ↵
- ↵
Hagerman RJ, Staley LW, O’Connor R, et al. Learning-disabled males with a fragile X CGG expansion in the upper premutation size range. Pediatrics . 1996; 97: 122–126.
- ↵
- ↵
- ↵
Hills JL, Wilson R, Sobesky W, et al. Executive functioning deficits in adult males with the fragile X permutation. Presented at the 7th International Fragile X Foundation Conference; July 19–22, 2000. Los Angeles, CA.
- ↵
Waring JD, Korueluk RG. Genetic studies of the myotonic dystrophy CTG repeat. In: Wells RD, Warren ST, eds. Genetic instabilities and heredity neurological diseases. New York: Academic Press; 1998: 131–146.
Letters: Rapid online correspondence
- Reply to Munoz
- RJ Hagerman, M.I.N.D. Institute, UC Davis Medical Centerrandi.hagerman@ucdmc.ucdavis.edu
- "C Greco, M Leehey, S Jacquemont, P Hagerman"
Submitted October 24, 2001 - Adult-onset neurodegeneration in Fragile X syndrome
- David G Munoz, Neurologist, Hospital Ruber Internacional, Madrid, Spaindave_munoz@yahoo.com
Submitted October 15, 2001
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. Sevil Yaşar and Dr. Behnam Sabayan
► Watch
Related Articles
- No related articles found.
Topics Discussed
Alert Me
Recommended articles
-
Articles
Volumetric brain changes in females with fragile X-associated tremor/ataxia syndrome (FXTAS)J. S. Adams, P. E. Adams, D. Nguyen et al.Neurology, August 27, 2007 -
Editorials
The variable phenotype of FXTASA common cause of “idiopathic” disordersChristoph Kamm, Thomas Gasser et al.Neurology, July 25, 2005 -
Articles
FXTASNew insights and the need for revised diagnostic criteriaEmmanuelle Apartis, Anne Blancher, Wassilios G. Meissner et al.Neurology, October 17, 2012 -
Article
X-inactivation in the clinical phenotype of fragile X premutation carrier sistersDeborah A. Hall, Erin E. Robertson-Dick, Joan A. O'Keefe et al.Neurology Genetics, February 03, 2016